Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report) announced its quarterly earnings data on Tuesday. Rhythm Pharmaceuticals Stock Up 2.2%Shares of NASDAQ RYTM traded up $2.38 during trading on Wednesday, hitting $108.16. Rhythm Pharmaceuticals has a fifty-two week low of $74.50 and a fifty-two week high of $122.20. JPMorgan Chase & Co. began coverage on shares of Rhythm Pharmaceuticals in a research note on Monday, July 27th. Further ReadingReceive News & Ratings for Rhythm Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhythm Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.